2022 Revenues ($USD) : $20,516,580,000
2022 Revenues (foreign currencies) : € 17,997,000,000
2022 R&D spend : $1,762,440,000
2022 Number of Employees : 66,100
Fiscal Year End : 9/30/2021
Company CEO : Bernd Montag, CEO

The German medtech giant is No. 3 among the Big 100 largest medical device companies of 2022. It has innovation roots that go back to the late 1890s, when it created its first medical X-ray device just one year after Wilhelm Conrad Roentgen discovered X-rays. Spun out of Siemens to become its own publicly traded company in 2018, Siemens Healthineers became even larger after closing its $16.4 billion acquisition of Varian Medical Systems in 2021. Siemens Healthineers said the merger with Varian created the industry's most comprehensive cancer care portfolio. The company’s cutting-edge technologies span imaging, diagnostics and cancer therapy. Recent wins included FDA clearance to integrate the company’s Cios Spin mobile cone-beam CT imaging tech with Intuitive’s Ion robot-assisted bronchoscopy system. Siemens Healthineers is sticking by its outlook for its current fiscal year that ends Sept. 30, 2022, even as it grapples with an unpredictable economic environment. –CN

*The 2022 Big 100 report is moving to September versus November in previous years. Because its fiscal year ends in September, Siemens Healthineers' revenue number is the same as in the 2021 report.